FDA approves Agios Pharmaceuticals’ Tibsovo for targeted acute myeloid leukemia treatment

The US Food and Drug Administration (FDA) has granted approval to Agios Pharmaceuticals for Tibsovo (ivosidenib), designed for the treatment of acute myeloid leukemia (AML) ... Read More